Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus

Human Gene Therapy

Volumn 18, Issue 5, 2007, Pages 423-434

  Beard, Brian C ^a   Keyser, Kirsten A ^a   Trobridge, Grant D ^a,b   Peterson, Laura J ^a   Miller, Daniel G ^b   Jacobs, Michael ^b   Kaul, Rajinder ^b   Kiem, Hans Peter ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DNA; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; LENTIVIRUS VECTOR; RETROVIRUS VECTOR; STEM CELL FACTOR; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD34 SELECTION; CELL TRANSPLANTATION; CPG ISLAND; DOG; FLOW CYTOMETRY; GENE ACTIVATION; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; IMMUNOSUPPRESSIVE TREATMENT; LENTIVIRINAE; LONG INTERSPERSED REPEAT; LONG TERMINAL REPEAT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTO ONCOGENE; RETROVIRUS; SHORT INTERSPERSED REPEAT; SPUMA VIRUS; TRANSCRIPTION INITIATION; VIRAL GENE DELIVERY SYSTEM; VIRUS DNA CELL DNA INTERACTION; WHOLE BODY RADIATION;

ANIMALS; BASE SEQUENCE; CPG ISLANDS; DNA PRIMERS; DOGS; GAMMARETROVIRUS; GENE THERAPY; GENETIC VECTORS; HUMANS; LENTIVIRUS; MODELS, ANIMAL; PROTO-ONCOGENES; REPETITIVE SEQUENCES, NUCLEIC ACID; SAFETY; SPUMAVIRUS; TRANSDUCTION, GENETIC; VIRUS INTEGRATION;

ANIMALIA; CANIS FAMILIARIS; GAMMARETROVIRUS; HUMAN SPUMARETROVIRUS; LENTIVIRUS;

EID: 34249804819     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.011     Document Type: Article

References (55)

1. AIUTI, A., SLAVIN, S., AKER, M., FICARA, F., DEOLA, S., MORTELLARO, A., MORECKI, S., ANDOLFI, G., TABUCCHI, A., CARLUCCI, F., MARINELLO, E., CATTANEO, F., VAI, S., SERVIDA, P., MINIERO, R., RONCAROLO, M.G., and BORDIGNON, C. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410-2413.
2. AKAGI, K., SUZUKI, T., STEPHENS, R.M., JENKINS, N.A., and COPELAND, N.G. (2004). RTCGD: Retroviral tagged cancer gene database. Nucleic Acids Res. 32, D523-D527.
3. ANTEQUERA, F., and BIRD, A. (1993a). CpG islands [review]. EXS 64, 169-185.
4. ANTEQUERA, F., and BIRD, A. (1993b). Number of CpG islands and genes in human arid mouse. Proc. Natl. Acad. Sci. U.S.A. 90, 11995-11999.
5. BAUM, C., VON KALLE, C., STAAL, F.J., LI, Z., FEHSE, B., SCHMIDT, M., WEERKAMP, F., KARLSSON, S., WAGEMAKER, G., and WILLIAMS, D.A, (2004). Chance or necessity? Insertional mutagenesis in gene therapy and its consequences [review], Mol. Ther. 9, 5-13.
6. BERNARDI, G., OLOFSSON, B., FILIPSKI, J., ZERIAL, M., SAUNAS, J., CUNY, G., MEUNIER-ROTIVAL, M., and RODIER, F. (1985). The mosaic genome of warm-blooded vertebrates. Science 228, 953-958.
7. BIRD, A.P. (1986). CpG-rich islands and the function of DNA methylation [review]. Nature 321, 209-213.
8. BUNTING, K.D., GALIPEAU, J., TOPHAM, D., BENAIM, E., and SORRENTINO, B.P. (1998). Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 92, 2269-2279.
9. BUSHMAN, F., LEWINSKI, M., CIUFFI, A., BARR, S., LEIPZIG, J., HANNENHALLI, S., and HOFFMANN, C. (2005). Genome-wide analysis of retroviral DNA integration [review]. Nat. Rev. Microbiol. 3, 848-858.
10. CALMELS, B., FERGUSON, C., LAUKKANEN, M.O., ADLER, R., FAULHABER, M., HYEOUNG-JOON, K., SELLERS, S., HEMATTI, P., SCHMIDT, M., VON KALLE, C., AKAGI, K., DONAHUE, R.E., and DUNBAR, C.E. (2005). Recurrent retroviral vector integration at the Mds1-Evil locus in nonhuman primate hematopoietic cells. Blood 106, 2530-2533.
11. CAVAZZANA-CALVO, M., HACEIN-BEY, S., DE SAINT BASILE, G., GROSS, F., YVON, E., NUSBAUM, P., SELZ, F., HUE, C., CERTAIN, S., CASANOVA, J.L., BOUSSO, P., DEIST, F.L., and FISCHER, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672.
12. DU, Y., JENKINS, N.A., and COPELAND, N.G. (2005). Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 106, 3932-3939.
13. DUNBAR, C.E., COTTLER-FOX, M., O'SHAUGHNESSY, J.A., DOREN, S., CARTER, C., BERENSON, R., BROWN, S., MOEN, R.C., GREENBLATT, J., STEWART, F.M., LEITMAN, S.F., WILSON, W.H., COWAN, K., YOUNG, N.S., and NIENHUIS, A.W. (1995). Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85, 3048-3057.
14. DUNBAR, C.E., SEIDEL, N.E., DOREN, S., SELLERS, S., CLINE, A.P., METZGER, M.E., AGRICOLA, B.A., DONAHUE, R.E., and BODINE, D.M. (1996). Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc. Natl. Acad. Sci. U.S.A. 93, 11871-11876.
15. FUTREAL, P.A., COIN, L., MARSHALL, M., DOWN, T., HUBBARD, T., WOOSTER, R., RAHMAN, N., and STRATTON, M.R. (2004). A census of human cancer genes [review]. Nat. Rev. Cancer 4, 177-183.
16. + marrow cells transduced by RD114-pseudotype oncoretrovirus vectors. Blood 98, 2065-2070.
17. GREZ, M., AKGUN, E., HILBERG, F., and OSTERTAG, W. (1990). Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 87, 9202-9206.
18. GREZ, M., ZORNIG, M., NOWOCK, J., and ZIEGLER, M. (1991). A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells. J. Virol. 65, 4691-4698.
19. HACEIN-BEY-ABINA, S., LE DEIST, F., CARLIER, F., BOUNEAUD, C., HUE, C., DE VILLARTAY, J.P., THRASHER, A.J., WULFFRAAT, N., SORENSEN, R., DUPUIS-GIROD, S., FISCHER, A., DA VIES, E.G., KUIS, W., LEIVA, L., and CAVAZZANA-CALVO, M. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185-1193.
20. HACEIN-BEY-ABINA, S., VON KALLE, C., SCHMIDT, M., Mc-CORMACK, M.P., WULFFRAAT, N., LEBOULCH, P., LIM, A., OSBORNE, C.S., PAWLIUK, R., MORILLON, E., SORENSEN, R., FORSTER, A., FRASER, P., COHEN, J.I., DE SAINT BASILE, G., ALEXANDER, I., WINTERGERST, U., FREBOURG, T., AURIAS, A., STOPPA-LYONNET, D., ROMANA, S., RADFORDWEISS, I., GROSS, F., VALENSI, F., DELABESSE, E., MACINTYRE, E., SIGAUX, F., SOULIER, J., LEIVA, L.E., WISSLER, M., PRINZ, C., RABBITTS, T.H., LE DEIST, F., FISCHER, A., and CAVAZZANA-CALVO, M. (2003a). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419.
21. HACEIN-BEY-ABINA, S., VON KALLE, C., SCHMIDT, M., LE DEIST, F., WULFFRAAT, N., McINTYRE, E., RADFORD, I., VILLEVAL, J.L., FRASER, C.C., CAVAZZANA-CALVO, M., and FISCHER, A. (2003b). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255-256.
22. HAWLEY, R.G. (2001). Progress toward vector design for hematopoietic stem cell gene therapy [review]. Curr. Gene Ther. 1, 1-17.
23. HEMATTI, P., HONG, B.K., FERGUSON, C., ADLER, R., HANAWA, H., SELLERS, S., HOLT, I.E., ECKFELDT, C.E., SHARMA, Y., SCHMIDT, M., VON KALLE, C., PERSONS, D.A., BILLINGS, E.M., VERFAILLIE, C.M., NIENHUIS, A.W., WOLFSBERG, T.G., DUNBAR, C.E., and CALMELS, B. (2004). Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2, e423.
24. HINRICHS, A.S., KAROLCHIK, D., BAERTSCH, R., BARBER, G.P., BEJERANO, G., CLAWSON, H., DIEKHANS, M., FUREY, T.S., HARTE, R.A., HSU, F., HILLMAN-JACKSON, J., KUHN, R.M., PEDERSEN, J.S., POHL, A., RANEY, B.J., ROSENBLOOM, K.R., SIEPEL, A., SMITH, K.E., SUGNET, C.W., SULTAN-QURRAIE, A., THOMAS, D.J., TRUMBOWER, H., WEBER, R.J., WEIRAUCH, M., ZWEIG, A.S., HAUSSLER, D., and KENT, W.J. (2006). The UCSC Genome Browser Database: Update 2006. Nucleic Acids Res. 34, D590-D598.
25. HOOKS, J.J., and GIBBS, C.J., JR. (1975). The foamy viruses [review]. Bacteriol. Rev. 39, 169-185.
26. HORN, P.A., MORRIS, J.C., BUKOVSKY, A.A., ANDREWS, R.G., NALDINI, L., KURRE, P., and KIEM, H.-P. (2002). Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons. Gene Ther. 9, 1464-1471.
27. HORN, P.A., KEYSER, K.A., PETERSON, L.J., NEFF, T., THOMASSON, B.M., THOMPSON, J., and KIEM, H.-P. (2004). Efficient lentiviral gene transfer to canine repopulating cells using an overnight transdustion protocol. Blood 103, 3710-3716.
28. ILAR (INSTITUTE OF LABORATORY ANIMAL RESEARCH). COMMISSION ON LIFE SCIENCES, NATIONAL RESEARCH COUNCIL. (1996). Guide for the Care and Use of Laboratory Animals. National Academies Press, Washington, D.C.
29. KENT, W.J. (2002). BLAT: The BLAST-like alignment tool. Genome Res. 12, 656-664.
30. KIEM, H.-P., SELLERS, S., THOMASSON, B., MORRIS, J.C., TISDALE, J.F., HORN, P.A., HEMATTI, P., ADLER, R., KURAMOTO, K., CALMELS, B., BONIFACINO, A., HU, J., VON KALLE, C., SCHMIDT, M., SORRENTINO, B., NIENHUIS, A., BLAU, C.A., ANDREWS, R.G., DONAHUE, R.E., and DUNBAR, C.E. (2004). Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: No progression to clonal hematopoiesis or leukemia. Mol. Ther. 9, 389-395.
31. KIEM, H.-P., ALLEN, J., TROBRIDGE, G., OLSON, E., KEYSER, K., PETERSON, L., and RUSSELL, D.W. (2007). Foamy virus-mediated gene transfer to canine repopulating cells. Blood 109, 65-70.
32. KUSTIKOVA, O., FEHSE, B., MODLICH, U., YANG, M., DULLMANN, J., KAMINO, K., VON NEUHOFF, N., SCHLEGELBERGER, B., LI, Z., and BAUM, C. (2005). Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308, 1171-1174.
33. LARSEN, F., GUNDERSEN, G., LOPEZ, R., and PRYDZ, H. (1992). CpG islands as gene markers in the human genome. Genomics 13, 1095-1107.
34. MILLER, N., and WHELAN, J. (1997). Progress in transcriptionally targeted and regulatable vectors for genetic therapy [review]. Hum. Gene Ther. 8, 803-815.
35. MITCHELL, R.S., BEITZEL, B.F., SCHRODER, A.R., SHINN, P., CHEN, H., BERRY, C.C., ECKER, J.R., and BUSHMAN, F.D. (2004). Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2, e234.
36. MODLICH, U., KUSTIKOVA, O.S., SCHMIDT, M., RUDOLPH, C., MEYER, J., LI, Z., KAMINO, K., VON NEUHOFF, N., SCHLEGELBERGER, B. , KUEHLCKE, K., BUNTING, K.D., SCHMIDT, S., DEICHMANN, A., VON KALLE, C., FEHSE, B., and BAUM, C. (2005). Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis. Blood 105, 4235-4246.
37. MUCENSKI, M.L., TAYLOR, B.A., COPELAND, N.G., and JENKINS, N.A. (1988). Chromosomal location of Evi-1, a common site of ecotropic viral integration in AKXD murine myeloid tumors. Oncogene Res. 2, 219-233.
38. NEFF, T., HORN, P.A., PETERSON, L.J., THOMASSON, B.M., THOMPSON, J., WILLIAMS, D.A., SCHMIDT, M., GEORGES, G.E., VON KALLE, C., and KIEM, H.-P. (2003). Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model. J. Clin. Invest. 112, 1581-1588.
39. NEFF, T., PETERSON, L.J., MORRIS, J.C., THOMPSON, J., ZHANG, X., HORN, P.A., THOMASSON, B.M., and KIEM, H.-P. (2004). Efficient gene transfer to hematopoietic repopulating cells using concentrated RD114-pseudotype vectors produced by human packaging cells [letter to the editor]. Mol. Ther. 9, 157-159.
40. NEFF, T., BEARD, B.C., PETERSON, L.J., ANANDAKUMAR, P., THOMPSON, J., and KIEM, H.-P. (2005). Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy. Blood 105, 997-1002.
41. NOWROUZI, A., DITTRICH, M., KLANKE, C., HEINKELEIN, M., RAMMLING, M., DANDEKAR, T., VON KALLE, C., and RETHWILM, A. (2006). Genome-wide mapping of foamy virus vector integrations into a human cell line. J. Gen. Virol. 87, 1339-1347.
42. OTT, M.G., SCHMIDT, M., SCHWARZWAELDER, K., STEIN, S., SILER, U., KOEHL, U., GLIMM, H., KUHLCKE, K., SCHILZ, A., KUNKEL, H., NAUNDORF, S., BRINKMANN, A., DEICHMANN, A., FISCHER, M., BALL, C., PILZ, I., DUNBAR, C., DU, Y., JENKINS, N.A., COPELAND, N.G., LUTHI, U., HASSAN, M., THRASHER, A.J., HOELZER, D., VON KALLE, C., SEGER, R., and GREZ, M. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12, 401-409.
43. 6-methyiguanine-DNA methyltransferase in hematopoietic cells. Mol. Ther. 13, 391-400.
44. SCHMIDT, M., ZICKLER, P., HOFFMANN, G., HAAS, S., WISSLER, M., MUESSIG, A., TISDALE, J.F., KURAMOTO, K., ANDREWS, R.G., WU, T., KIEM, H.-P., DUNBAR, C.E., and VON KALLE, C. (2002). Polyclonal long-term repopulating stem cell clones in a primate model. Blood 100, 2737-2743.
45. + cells from the cord blood of ADA-deficient SCID neonates. Nat. Med. 9, 463-468.
46. SCHRODER, A.R., SHINN, P., CHEN, H., BERRY, C., ECKER, J.R., and BUSHMAN, F. (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521-529.
47. SONG, B., JAVANBAKHT, H., PERRON, M., PARK, D.H., STREMLAU, M., and SODROSKI, J. (2005). Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. J. Virol. 79, 3930-3937.
48. STREMLAU, M., OWENS, C.M., PERRON, M.J., KIESSLING, M., AUTISSIER, P., and SODROSKI, J. (2004). The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853.
49. TROBRIDGE G., JOSEPHSON, N., VASSILOPOULOS, G., MAC, J., and RUSSELL, D.W. (2002). Improved foamy virus vectors with minimal viral sequences. Mol. Ther. 6, 321-328.
50. TROBRIDGE, G.D., MILLER, D.G., JACOBS, M.A., ALLEN, J.M., KIEM, H.-P., KAUL, R., and RUSSELL, D.W. (2006). Foamy virus vector integration sites in normal human cells. Proc. Natl. Acad. Sci. U.S.A. 103, 1498-1503.
51. VON KALLE, C., FEHSE, B., LAYH-SCHMITT, G., SCHMIDT, M., KELLY, P., and BAUM, C. (2004). Stem cell clonality and genotoxicity in hematopoietic cells: Gene activation side effects should be avoidable. Semin. Hematol. 41, 303-318.
52. + progenitors using clinically feasible methods. Mol. Ther. 1, 285-293.
53. WU, X., LI, Y., CRISE, B., and BURGESS, S.M. (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science 300, 1749-1751.
54. ZUFFEREY, R., NAGY, D., MANDEL, R.J., NALDINI, L., and TRONO, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871-875.
55. ZUFFEREY, R., DULL, T., MANDEL, R.J., BUKOVSKY, A., QUIROZ, D., NALDINI, L., and TRONO, D. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873-9880.